Biomarker could help doctors tailor treatment for rheumatoid arthritis
Friday, January 29, 2010 - 12:35
in Health & Medicine
Investigators have identified a biomarker that could help doctors select patients with rheumatoid arthritis who will benefit from therapy with drugs such as Enbrel, a tumor necrosis factor-antagonist drug.